Wanlong Ma NeoGenomics Laboratories Biography Publications Institution JoVE Articles Wanlong Ma has not added a biography. If you are Wanlong Ma and would like to personalize this page please email our Author Liaison for assistance. Publications Using High-sensitivity Sequencing for the Detection of Mutations in BTK and PLCγ2 Genes in Cellular and Cell-free DNA and Correlation with Progression in Patients Treated with BTK Inhibitors Oncotarget. Feb, 2017 | Pubmed ID: 28212557 Resistance to Imatinib in Patients with Chronic Myelogenous Leukemia and the Splice Variant BCR-ABL1(35INS) Leukemia Research. Oct, 2016 | Pubmed ID: 27658269 Deep Sequencing of Cell-Free Peripheral Blood DNA As a Reliable Method for Confirming the Diagnosis of Myelodysplastic Syndrome Genetic Testing and Molecular Biomarkers. Jul, 2016 | Pubmed ID: 27248906 Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring System Journal of Cancer. 2016 | Pubmed ID: 26918043 Synonymous Polymorphisms in HOXB13 As a Protective Factor for Prostate Cancer Journal of Cancer. 2015 | Pubmed ID: 25874003 Diagnostic and Prognostic Scoring System for Prostate Cancer Using Urine and Plasma Biomarkers Genetic Testing and Molecular Biomarkers. Mar, 2014 | Pubmed ID: 24512523 Plasma Ubiquitin-proteasome System Profile in Patients with Multiple Sclerosis: Correlation with Clinical Features, Neuroimaging, and Treatment with Interferon-beta-1b Neurological Research. Jul, 2012 | Pubmed ID: 22709658 BCR-JAK2 Fusion As a Result of a Translocation (9;22)(p24;q11.2) in a Patient with CML-like Myeloproliferative Disease Molecular Cytogenetics. May, 2012 | Pubmed ID: 22549126 Effects of Clinically Relevant MPL Mutations in the Transmembrane Domain Revealed at the Atomic Level Through Computational Modeling PloS One. 2011 | Pubmed ID: 21858098 Ubiquitin-proteasome Profiling for Enhanced Detection of Hepatocellular Carcinoma in Patients with Chronic Liver Disease Journal of Gastroenterology and Hepatology. Apr, 2011 | Pubmed ID: 21418304 MPL Mutation Profile in JAK2 Mutation-negative Patients with Myeloproliferative Disorders Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B. Mar, 2011 | Pubmed ID: 21326037 Ubiquitin-proteasome System Profiling in Acute Leukemias and Its Clinical Relevance Leukemia Research. Apr, 2011 | Pubmed ID: 20951430 Significant Association Between Polymorphism of the Erythropoietin Gene Promoter and Myelodysplastic Syndrome BMC Medical Genetics. Nov, 2010 | Pubmed ID: 21078205 JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms PloS One. Aug, 2010 | Pubmed ID: 20730051 Circulating Ki-67 Index in Plasma As a Biomarker and Prognostic Indicator in Chronic Lymphocytic Leukemia Leukemia Research. Oct, 2010 | Pubmed ID: 20362333 Circulating Ki-67 Protein in Plasma As a Biomarker and Prognostic Indicator of Acute Lymphoblastic Leukemia Leukemia Research. Feb, 2010 | Pubmed ID: 19679351 Structural Effects of Clinically Observed Mutations in JAK2 Exons 13-15: Comparison with V617F and Exon 12 Mutations BMC Structural Biology. Sep, 2009 | Pubmed ID: 19744331 Proteasome Enzymatic Activities in Plasma As Risk Stratification of Patients with Acute Myeloid Leukemia and Advanced-stage Myelodysplastic Syndrome Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Jun, 2009 | Pubmed ID: 19458051 BCR-ABL Truncation Due to Premature Translation Termination As a Mechanism of Resistance to Kinase Inhibitors Acta Haematologica. 2009 | Pubmed ID: 19332983 Detection of Nucleophosmin Gene Mutations in Plasma from Patients with Acute Myeloid Leukemia: Clinical Significance and Implications Cancer Biomarkers : Section A of Disease Markers. 2009 | Pubmed ID: 19242062 K-ras Mutations and Cetuximab in Colorectal Cancer The New England Journal of Medicine. Feb, 2009 | Pubmed ID: 19238675 B-cell Clones As Early Markers for Chronic Lymphocytic Leukemia The New England Journal of Medicine. Feb, 2009 | Pubmed ID: 19213679 Mechanisms of Constitutive Activation of Janus Kinase 2-V617F Revealed at the Atomic Level Through Molecular Dynamics Simulations Cancer. Apr, 2009 | Pubmed ID: 19195039 Mutation Profile of JAK2 Transcripts in Patients with Chronic Myeloproliferative Neoplasias The Journal of Molecular Diagnostics : JMD. Jan, 2009 | Pubmed ID: 19074595 BCR-ABL Alternative Splicing As a Common Mechanism for Imatinib Resistance: Evidence from Molecular Dynamics Simulations Molecular Cancer Therapeutics. Dec, 2008 | Pubmed ID: 19056677 Higher Detection Rate of JAK2 Mutation Using Plasma Blood. Apr, 2008 | Pubmed ID: 18362222 Enzymatic Activity of Circulating Proteasomes Correlates with Clinical Behavior in Patients with Chronic Lymphocytic Leukemia Cancer. Mar, 2008 | Pubmed ID: 18224667 Bi-clonal Disease in Patients with Chronic Lymphocytic Leukaemia As Detected by Analysing IGHV Mutation Status British Journal of Haematology. Nov, 2007 | Pubmed ID: 17868045 Plasma RNA As an Alternative to Cells for Monitoring Molecular Response in Patients with Chronic Myeloid Leukemia Haematologica. Feb, 2007 | Pubmed ID: 17296565 Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations Adam Z. Albitar1, Wanlong Ma1, Maher Albitar1 1NeoGenomics Laboratories JoVE 55130 유전학
Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations Adam Z. Albitar1, Wanlong Ma1, Maher Albitar1 1NeoGenomics Laboratories JoVE 55130 유전학